Literature DB >> 33941754

Beta 2-adrenergic receptor mediates noradrenergic action to induce cyclic adenosine monophosphate response element-binding protein phosphorylation in satellite glial cells of dorsal root ganglia to regulate visceral hypersensitivity.

Shanwei Shen1, Namrata Tiwari, Jonathan Madar, Parshva Mehta, Liya Y Qiao.   

Abstract

ABSTRACT: Sympathoneuronal outflow into dorsal root ganglia (DRG) is suggested to be involved in sympathetically maintained chronic pain, which is mediated by norepinephrine (NE) action on DRG cells. This study combined in vitro and in vivo approaches to identify the cell types of DRG that received NE action and examined cell type-specific expression of adrenergic receptors (ARs) in DRG. Using DRG explants, we identified that NE acted on satellite glial cells (SGCs) to induce the phosphorylation of cAMP response element-binding protein (CREB). Using primarily cultured SGCs, we identified that beta (β)2-adrenergic receptor but not alpha (α)adrenergic receptor nor other βAR isoforms mediated NE-induced CREB phosphorylation and CRE-promoted luciferase transcriptional activity. Using fluorescence in situ hybridization and affinity purification of mRNA from specific cell types, we identified that β2AR was expressed by SGCs but not DRG neurons. We further examined β2AR expression and CREB phosphorylation in vivo in a model of colitis in which sympathetic nerve sprouting in DRG was observed. We found that β2AR expression and CREB phosphorylation were increased in SGCs of thoracolumbar DRG on day 7 after colitis induction. Inhibition but not augmentation of β2AR reduced colitis-induced calcitonin gene-related peptide release into the spinal cord dorsal horn and colonic pain responses to colorectal distention. Prolonged activation of β2AR in naive DRG increased calcitonin gene-related peptide expression in DRG neurons. These findings provide molecular basis of sympathetic modulation of sensory activity and chronic pain that involves β2AR-mediated signaling in SGCs of DRG.
Copyright © 2021 International Association for the Study of Pain.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 33941754      PMCID: PMC8556417          DOI: 10.1097/j.pain.0000000000002330

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  67 in total

1.  ATP and noradrenaline activate CREB in astrocytes via noncanonical Ca(2+) and cyclic AMP independent pathways.

Authors:  Paulina Carriba; Luis Pardo; Arnaldo Parra-Damas; Mathieu P Lichtenstein; Carlos A Saura; Aurora Pujol; Roser Masgrau; Elena Galea
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

2.  Coupled Activation of Primary Sensory Neurons Contributes to Chronic Pain.

Authors:  Yu Shin Kim; Michael Anderson; Kyoungsook Park; Qin Zheng; Amit Agarwal; Catherine Gong; LeAnne Young; Shaoqiu He; Pamela Colleen LaVinka; Fengquan Zhou; Dwight Bergles; Menachem Hanani; Yun Guan; David C Spray; Xinzhong Dong
Journal:  Neuron       Date:  2016-08-25       Impact factor: 17.173

3.  Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

Authors:  Y Daaka; L M Luttrell; R J Lefkowitz
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

4.  Prolonged sympathetic innervation of sensory neurons in rat thoracolumbar dorsal root ganglia during chronic colitis.

Authors:  C-M Xia; D G Colomb; H I Akbarali; L-Y Qiao
Journal:  Neurogastroenterol Motil       Date:  2011-05-24       Impact factor: 3.598

5.  Adrenergic β2-receptor mediates itch hypersensitivity following heterotypic chronic stress in rats.

Authors:  Xiao-Yan Peng; Ya Huang; Xue-Long Wang; Lei-Fang Cao; Li-Hua Chen; Wei-Feng Luo; Tong Liu
Journal:  Neuroreport       Date:  2015-12-02       Impact factor: 1.837

Review 6.  Spinal neuron-glia-immune interaction in cross-organ sensitization.

Authors:  Liya Y Qiao; Namrata Tiwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-10-21       Impact factor: 4.052

7.  Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain.

Authors:  Ipek Yalcin; Luc-Henri Tessier; Nathalie Petit-Demoulière; Elisabeth Waltisperger; Lutz Hein; Marie-José Freund-Mercier; Michel Barrot
Journal:  Exp Neurol       Date:  2009-10-17       Impact factor: 5.330

8.  A CREB-mediated increase in miRNA let-7f during prolonged β-agonist exposure: a novel mechanism of β2-adrenergic receptor down-regulation in airway smooth muscle.

Authors:  Donghwa Kim; Soomin Cho; Jung A Woo; Stephen B Liggett
Journal:  FASEB J       Date:  2018-02-13       Impact factor: 5.191

Review 9.  Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling.

Authors:  Paul A Insel; Rennolds S Ostrom
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

10.  Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress.

Authors:  John H Winston; Guang-Yin Xu; Sushil K Sarna
Journal:  Gastroenterology       Date:  2009-10-01       Impact factor: 22.682

View more
  3 in total

1.  Sympathetic modulation of tumor necrosis factor alpha-induced nociception in the presence of oral squamous cell carcinoma.

Authors:  Megan Atherton; Stella Park; Nicole L Horan; Samuel Nicholson; John C Dolan; Brian L Schmidt; Nicole N Scheff
Journal:  Pain       Date:  2022-04-20       Impact factor: 7.926

2.  The cAMP Response Element- Binding Protein/Brain-Derived Neurotrophic Factor Pathway in Anterior Cingulate Cortex Regulates Neuropathic Pain and Anxiodepression Like Behaviors in Rats.

Authors:  Jing Wen; Yaowei Xu; Zhixiang Yu; Yifan Zhou; Wenting Wang; Jingjie Yang; Yiming Wang; Qian Bai; Zhisong Li
Journal:  Front Mol Neurosci       Date:  2022-03-24       Impact factor: 5.639

3.  Sustainable Release of Propranolol Hydrochloride Laden with Biconjugated-Ufasomes Chitosan Hydrogel Attenuates Cisplatin-Induced Sciatic Nerve Damage in In Vitro/In Vivo Evaluation.

Authors:  Yasmin M Ahmed; Raha Orfali; Doaa S Hamad; Mostafa E Rateb; Hanan O Farouk
Journal:  Pharmaceutics       Date:  2022-07-23       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.